AGENO, WALTER
 Distribuzione geografica
Continente #
NA - Nord America 1.772
EU - Europa 1.467
AS - Asia 461
AF - Africa 42
OC - Oceania 42
SA - Sud America 27
Continente sconosciuto - Info sul continente non disponibili 5
Totale 3.816
Nazione #
US - Stati Uniti d'America 1.708
DE - Germania 881
CN - Cina 214
IT - Italia 182
GB - Regno Unito 102
VN - Vietnam 58
IN - India 53
CA - Canada 51
FR - Francia 50
RU - Federazione Russa 46
AU - Australia 39
IE - Irlanda 34
CZ - Repubblica Ceca 28
ID - Indonesia 23
ES - Italia 22
JP - Giappone 22
ZA - Sudafrica 20
NL - Olanda 19
UA - Ucraina 18
IR - Iran 14
TH - Thailandia 14
CL - Cile 10
RO - Romania 9
HK - Hong Kong 8
MX - Messico 7
PH - Filippine 7
SG - Singapore 7
BR - Brasile 6
EG - Egitto 6
FI - Finlandia 6
GR - Grecia 6
IL - Israele 6
KR - Corea 6
LV - Lettonia 6
NO - Norvegia 6
PT - Portogallo 6
TR - Turchia 6
BE - Belgio 5
CH - Svizzera 5
CO - Colombia 5
EU - Europa 5
MY - Malesia 5
RS - Serbia 5
TW - Taiwan 5
AT - Austria 4
GH - Ghana 4
LT - Lituania 4
MK - Macedonia 4
PL - Polonia 4
DK - Danimarca 3
MT - Malta 3
NZ - Nuova Zelanda 3
OM - Oman 3
PE - Perù 3
PK - Pakistan 3
AR - Argentina 2
BY - Bielorussia 2
DZ - Algeria 2
KZ - Kazakistan 2
MA - Marocco 2
PR - Porto Rico 2
SD - Sudan 2
SE - Svezia 2
SK - Slovacchia (Repubblica Slovacca) 2
AG - Antigua e Barbuda 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
CM - Camerun 1
CR - Costa Rica 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
KW - Kuwait 1
LB - Libano 1
ME - Montenegro 1
NG - Nigeria 1
NP - Nepal 1
QA - Qatar 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YE - Yemen 1
ZM - Zambia 1
Totale 3.816
Città #
Fairfield 181
Houston 169
Woodbridge 146
Ann Arbor 109
Ashburn 102
Buffalo 98
Seattle 89
Santa Cruz 74
Beijing 69
Cambridge 65
Nürnberg 60
Hangzhou 53
Wilmington 48
Como 43
Dong Ket 28
Dublin 22
Chicago 20
Las Vegas 20
Wuhan 20
Ottawa 19
Muizenberg 18
University Park 15
Varese 15
Phoenix 13
San Diego 13
Bengaluru 12
Los Angeles 12
Boardman 11
Shanghai 11
Fleming Island 10
Mountain View 10
Melbourne 9
Hanoi 8
Leawood 8
Madrid 8
Paris 8
Scranton 8
Toronto 8
Easton 7
Hamilton 7
London 7
New York 7
Boston 6
Chongqing 6
Dallas 6
Helsinki 6
Henderson 6
Milan 6
Rome 6
Tehran 6
Blackwood 5
Boulder 5
Cagliari 5
Clearwater 5
Jinan 5
Montréal 5
Mumbai 5
Amsterdam 4
Avignon 4
Brisbane 4
Carate Brianza 4
Cleveland 4
Duncan 4
Hyderabad 4
Karaj 4
Lake Forest 4
New Delhi 4
Omaha 4
Philadelphia 4
Poole 4
Riva 4
Saint Petersburg 4
San Francisco 4
Singapore 4
Sydney 4
Tokyo 4
Adelaide 3
Athens 3
Austin 3
Baltimore 3
Bangalore 3
Basiglio 3
Bogotá 3
Brooklyn 3
Bury 3
Canberra 3
Central 3
Council Bluffs 3
Denver 3
Detroit 3
Fasano 3
Guangzhou 3
Istanbul 3
Jacksonville 3
Jakarta 3
Kobe 3
Leuven 3
Lexington 3
Lima 3
Madison 3
Totale 1.891
Nome #
Impact of glomerular filtration estimate on bleeding risk in very old patients treated with vitamin K antagonists. Results of EPICA study on the behalf of FCSA (Italian Federation of Anticoagulation Clinics)., file e2188be6-015d-4564-e053-6605fe0a49d6 676
Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis, file e2188be5-f9d2-4564-e053-6605fe0a49d6 546
Interventional treatment of venous thromboembolism: a review., file e2188be6-0158-4564-e053-6605fe0a49d6 452
Retrievable vena cava filters: a clinical review., file e2188be6-0159-4564-e053-6605fe0a49d6 256
Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients., file e2188be6-015c-4564-e053-6605fe0a49d6 245
Should the commonly accepted definition of "unprovoked venous thrombembolism" be revisited?, file e2188be6-015b-4564-e053-6605fe0a49d6 183
Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines., file e2188be6-015a-4564-e053-6605fe0a49d6 177
Folic acid supplementation and cardiovascular diseases, file e2188be6-a367-4564-e053-6605fe0a49d6 174
Statins, fibrates, and venous thromboembolism: a meta-analysis., file e2188be5-fef4-4564-e053-6605fe0a49d6 172
Clinical characteristics and management of cancer-associated acute venous thromboembolism: findings from the MASTER Registry., file e2188be6-6206-4564-e053-6605fe0a49d6 131
The metabolic syndrome and the risk of thrombosis, file e2188be6-6204-4564-e053-6605fe0a49d6 124
Incidental Diagnosis of Deep Vein Thrombosis in Consecutive Patients Undergoing a CT Scan of the Abdomen: a Retrospective Cohort Study., file e2188be5-ffb4-4564-e053-6605fe0a49d6 120
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study, file e2188be6-650e-4564-e053-6605fe0a49d6 117
Fluctuations in warfarin dose response after heart valve surgery: implications for cardiac rehabilitation., file e2188be6-6281-4564-e053-6605fe0a49d6 107
Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry., file e2188be6-9502-4564-e053-6605fe0a49d6 85
Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty, file e2188be7-12d4-4564-e053-6605fe0a49d6 84
Prevalence and prevention of venous thromboembolism in patients with acute exacerbations of COPD, file e2188be5-fd08-4564-e053-6605fe0a49d6 82
Cardiovascular risk factors and venous thromboembolism: a meta-analysis., file e2188be5-f958-4564-e053-6605fe0a49d6 32
Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial., file e2188be5-f959-4564-e053-6605fe0a49d6 28
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET), file e2188be8-2775-4564-e053-6605fe0a49d6 19
Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial., file e2188be5-fd39-4564-e053-6605fe0a49d6 18
null, file e2188be8-1d16-4564-e053-6605fe0a49d6 15
High-Sensitivity Cardiac Troponin T and the Diagnosis of Cardiovascular Disease in the Emergency Room: The Importance of Combining Cardiovascular Biomarkers with Clinical Data, file 04a7ca07-bee8-4324-9001-aa0e6ca35d6c 7
Immune-mediated mechanisms in patients tested positive for SARS-CoV-2: Protocol for a multianalysis study, file 098b9e8a-3b39-4d02-9cc2-34fec85ff7dd 7
Anticoagulation in Italian patients with venous thromboembolism and thrombophilic alterations: findings from START2 register study, file 25b9550a-249d-4524-aacf-5882118ed94d 7
Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: A Delphi analysis of experts, file e2188be7-95b8-4564-e053-6605fe0a49d6 7
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study., file 3ec6b835-c726-4bee-8a90-a81bb951878c 6
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?, file effd442e-8aed-4136-9e0e-b2c27684b104 6
Assessment of Outcomes Among Patients With Venous Thromboembolism With and Without Chronic Kidney Disease, file be4fdd12-3e7a-4722-8bcc-d8c805fbd618 5
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment, file e2188be6-9aa5-4564-e053-6605fe0a49d6 5
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy, file e2188be7-cd8d-4564-e053-6605fe0a49d6 5
Reduced-Dose Intravenous Thrombolysis for Acute Intermediate-High-risk Pulmonary Embolism: Rationale and Design of the Pulmonary Embolism International THrOmbolysis (PEITHO)-3 trial, file ca98622f-a4bf-4874-8522-46a5cea55f2c 4
In vitro effects of Apixaban on 5 different cancer cell lines, file e2188be6-d9f9-4564-e053-6605fe0a49d6 4
RAPID SALIVARY TEST SUITABLE FOR A MASS SCREENING PROGRAM TO DETECT SARS-COV-2: A DIAGNOSTIC ACCURACY STUDY, file e2188be7-d4b5-4564-e053-6605fe0a49d6 4
Novel biomarkers to detect occult cancer in patients with unprovoked venous thromboembolism: Rationale and design of the PLATO-VTE study, file fa696af9-fcf6-40b4-9260-5a9464ea4eed 4
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry, file 04440b81-851e-40ac-bdfa-d8534bd53bb3 3
Anticoagulation in splanchnic and cerebral vein thrombosis: An international vignette-based survey, file 3ceefa7b-6d23-4ca9-8334-df57b5da909d 3
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study, file 8820fe89-ab82-4497-8d60-ef0702e2f390 3
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry, file 945e513e-65ac-499d-aa84-d1c47fafa114 3
Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register, file 94d3b794-13bc-4e48-b777-01ffb2fc72e8 3
SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients, file e2188be7-cd88-4564-e053-6605fe0a49d6 3
Safety and effectiveness of biosimilar enoxaparin (Inhixa) for the prevention of thromboembolism in medical and surgical inpatients, file 000db8f5-9a55-41fa-85c5-996d7bbe4ad1 2
Incidence of chronic thromboembolic pulmonary hypertension after a first episode of pulmonary embolism, file aafae7a7-9229-4c6e-95f2-9895639a8388 2
Prognostic value of trans-thoracic echocardiography in patients with acute stroke and atrial fibrillation: findings from the RAF study, file e2188be6-3a4b-4564-e053-6605fe0a49d6 2
Oral vitamin K lowers the international normalized ratio more rapidly than subcutaneous vitamin K in the treatment of warfarin-associated coagulopathy: A randomized, controlled trial, file e2188be6-9b5a-4564-e053-6605fe0a49d6 2
Timing of anticoagulation for portal vein thrombosis in liver cirrhosis: An Italian internist's perspective, file f93981d5-8be5-464d-9c46-4363a66e405b 2
The association between neonatal ABO blood group and intraventricular hemorrhage in extremely low birth weight infants: A reply to a comment, file 1d788e75-89d8-4a51-bead-61c58c76b17e 1
The predictive ability of bleeding risk stratification models in very old patients on vitamin K antagonist treatment for venous thromboembolism: Results of the prospective collaborative EPICA study: Reply, file 2159eef3-dd8e-4b67-83ff-04be7458aa31 1
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study, file 374e06cf-a498-40a6-bd15-da3c0a037d36 1
2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19, file 3f0fa67c-8a71-4ca8-b946-48d9620fa55a 1
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation, file e2188be7-fb27-4564-e053-6605fe0a49d6 1
Totale 3.947
Categoria #
all - tutte 6.745
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.745


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019416 0 0 10 28 22 25 32 11 32 61 104 91
2019/2020714 75 68 58 99 56 73 47 56 56 43 33 50
2020/2021505 37 47 32 37 54 25 52 37 36 43 47 58
2021/2022694 50 55 29 114 109 33 44 24 49 20 127 40
2022/2023573 21 37 113 61 36 35 46 35 56 42 52 39
2023/202480 20 38 22 0 0 0 0 0 0 0 0 0
Totale 3.947